H. de Crémoux

发表

Influence of pretreatment clinical characteristics on the response rate to mitomycin/vindesine/cisplatin (MVP) in unresectable non-small cell lung cancer. ATTIT (Association pour le Traitement des Tumeurs Intra-Thoraciques).

M. Riggi, E. Cvitkovic, L. Vergne, 1991, European journal of cancer.

Prospective screening for ALK: clinical features and outcome according to ALK status.

M. Antoine, M. Wislez, T. Chinet, 2014, European journal of cancer.

Phase I/II study of escalating doses of vinorelbine in combination with oxaliplatin in patients with advanced non-small-cell lung cancer.

P. Soulié, E. Brain, M. Bekradda, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recurrent chromosome aberrations in human lung squamous cell carcinomas.

B. Dutrillaux, J. Bignon, E. Viégas-Péquignot, 1990, Cancer genetics and cytogenetics.

Cytogenetic study of five cases of lung adenosquamous carcinomas.

B. Dutrillaux, J. Bignon, E. Viégas-Péquignot, 1992, Cancer genetics and cytogenetics.

Bronchoalveolar disease in dyskeratosis congenita.

P. Saiag, J. Bignon, F. Verra, 1992, The European respiratory journal.

Interactions between cigarette smoking and the natural history of idiopathic pulmonary fibrosis.

P Brochard, J. Bernaudin, P. Brochard, 1990, Chest.

Alternating radiotherapy and chemotherapy in limited small cell lung cancer: the IGR protocols. French FNCLCC Lung Cancer Study Group.

R. Arriagada, T. le Chevalier, P. Ruffié, 1994, Lung cancer.

Systemic mast cell disease associated with primary mediastinal germ cell tumor.

J. Droz, P. Chariot, I. Monnet, 1991, The American journal of medicine.

Partial characterisation of an elastase‐like enzyme secreted by human and monkey alveolar macrophages

M. Jaurand, W. Hornebeck, J. Bignon, 1978, The Journal of pathology.

Competing events determining relapse-free survival in limited small-cell lung carcinoma. The French Cancer Centers' Lung Group.

R. Arriagada, T. le Chevalier, A. Kramar, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers.

J. Bernaudin, F. Lebargy, E. Escudier, 1995, American journal of respiratory and critical care medicine.

An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients.

S. Culine, J. Trédaniel, J. Alexandre, 2009, Lung cancer.

Features of asbestos-exposed and unexposed mesothelioma.

P. Brochard, J. Bignon, L. Di Menza, 1982, American journal of industrial medicine.

Systemic mastocytosis following mediastinal germ cell tumor: an association confirmed.

P. Gaulard, P. Chariot, I. Monnet, 1993, Human pathology.

Lack of a relationship between the polymorphism of debrisoquine oxidation and lung cancer.

J. Dalphin, P. Bechtel, J. Barré, 1991, British journal of clinical pharmacology.

Pathological and pathogenetic aspects of chronic obstructive lung disease.

J. Bignon, H. de Cremoux, H. de Crémoux, 1980, Bulletin europeen de physiopathologie respiratoire.

[Dental prosthesis technician, a subject with risk of Erasmus syndrome. Apropos of a case].

J. Roujeau, O. Chosidow, J. Revuz, 1991, Annales de dermatologie et de venereologie.

Alternating radiotherapy and chemotherapy in 173 consecutive patients with limited small cell lung carcinoma. GROP and the French Cancer Center's Lung Group.

R. Arriagada, T. le Chevalier, P. Baldeyrou, 1990, International journal of radiation oncology, biology, physics.